You mentioned that you are working with the U.K. and France. I know it's one of the things we talked about at the neurological disorders committee when we briefly started--that is, about how we can work with partners abroad more to learn from some of their research. One thing we heard was that some countries had positive studies on delaying onset. Can you tell us a little bit more about the partnership with France and the U.K. and the type of work Canada is doing with other countries? That sounds very interesting.
It's great to see that you put an emphasis on Alzheimer's. I know that in my own community, every January we have our Alzheimer's walk and every year it gets bigger and bigger because so many families are affected by it. It's a huge concern in Barrie, and I'm sure for all Canadians.